Aim: To evaluate the prediction capacity of urinary biomarkers for death in critically ill patients with COVID-19. Methods: This is a prospective study with critically ill patients due to COVID-19 ...
Snakebite antivenom (SAV) is the standard treatment option to neutralize the toxic effects of snake venom, but their consequences on kidney function need to be better understood. This study aims to evaluate the effects of antivenom on kidney and endothelial biomarkers due to Bothrops venom in two subgroups of patients distinguished by the presence of hemorrhagic syndrome at admission. This prospective study included 34 snakebite patients admitted to a tertiary hospital in Northeast Brazil between August 2019 and November 2020, 50 % of whom experienced spontaneous bleeding. Endothelial and kidney damage biomarkers were analyzed at three time points: before antivenom infusion and after 10 h and 20 h of antivenom infusion. Bleeding patients exhibited higher urine Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and Kidney Injury Molecule-1 (KIM-1) levels, indicating incomplete renal recovery until 20h after antivenom. This group showed higher serum angiopoietin-2 (Ang-2) levels and vascular cell adhesion molecule-1 (VCAM-1). VCAM-1 levels positively correlated with kidney biomarker levels at each time point, especially after SAV. uNGAL was variant across VCAM-1, Ang-1, and Ang-2 levels before antivenom. Elevated levels of uNGAL and KIM-1, observed 10 h after SAV administration, may indicate incomplete renal protection and a potential risk for the development of chronic kidney injury, requiring future follow-up.
Aim: To evaluate the urinary biomarkers related to sepsis in preterm newborns (NBs) and to investigate the predictive capacity of these biomarkers for a longer hospital stay.Methods: Serum and urine were collected from 27 healthy NBs, 24 NBs with neonatal infection without sepsis and 11 NBs with sepsis for the measurement of sindecan-1, lipocalin associated with urinary neutrophil gelatinase (uNGAL), urinary cystatin-C (uCysC) and urinary kidney injury molecule-1.Results: Levels of uNGAL and urinary cystatin-C were elevated in NBs with sepsis and neonatal infection, and uNGAL was significant predictor of hospital stay longer than 30 days (odds ratio: 1.052; 95% CI: 1.012-1.093; p = 0.01).Conclusion: uNGAL was associated with sepsis in preterm NBs and was useful to predict extended hospital stay.
28 February 2025 in International Journal of STD & AIDS
Background: HIV infection is associated with various types of endothelial damage. Early and accurate diagnosis of endothelial dysfunction may help prevent adverse outcomes. For the first time, this cross-sectional study aims to investigate the effects of increased viral load on endothelial damage and nephrinuria in untreated people living with HIV. Methods: People living with HIV not on treatment were included. Laboratory parameters, such as viral load and CD4 count were collected. Participants were divided into three groups according to the tertiles of viral load: low, moderate and high viral load groups. Urinary nephrin, vascular cell adhesion molecule 1 (VCAM-1), angiopoietin-2 and syndecan-1 were quantified by sandwich ELISA assays kits. Results: A total of 49 patients were examined. The high viral load group (3rd tertile) exhibited a greater frequency of nephrinuria and significantly higher levels of syndecan-1 (58 [48–93] vs 43 [38–65] ng/mL, p = .049) and angiopoietin-2 (2.58 [1.5–3.06] vs 1.34 [0.89–1.76] ng/mL, p = .035). Syndecan-1 levels positively correlated with viral load (rho = 0.452, p = .006), while angiopoietin-2 was positively correlated with viral load (rho = 0.529, p = .001) and inversely correlated with CD4 count (rho = −0.493, p = .003). No significant associations were found for VCAM-1 levels. Conclusion: Untreated people living with HIV with elevated viral loads exhibited more pronounced endothelial damage and vascular inflammation, emphasizing the critical importance of early initiation of antiretroviral treatment to mitigate these complications. However, the study’s findings should be interpreted with caution due to the small sample size, which may limit the generalizability of the results. Future studies with larger cohorts are needed to confirm these findings.
10 November 2026 in Brazilian Journal of Nephrology
RESUMO Introdução: A doença renal crônica (DRC) está associada à disbiose intestinal, inflamação sistêmica e comprometimento da função da barreira intestinal. A zonulina sérica tem sido proposta como um marcador indireto da permeabilidade intestinal, embora sua relevância clínica na DRC permaneça incerta. Objetivo: Avaliar o efeito da suplementação com probióticos nos níveis séricos de zonulina em pacientes submetidos à hemodiálise de manutenção. Métodos: Ensaio clínico randomizado, controlado por placebo e triplo-cego, no qual 40 pacientes em hemodiálise foram designados para receber uma formulação probiótica ou placebo durante seis meses. O desfecho primário foi a diferença entre os grupos na alteração dos níveis séricos de zonulina do início ao acompanhamento. Os desfechos secundários incluíram variáveis metabólicas, antropométricas, hemodinâmicas e gastrointestinais. Resultados: Os níveis séricos de zonulina aumentaram em ambos os grupos, sem diferença significativa entre eles (placebo: 288,2 a 425,3 ng/mL; probiótico: 239,5 a 453,7 ng/mL; p = 0,882; ANCOVA p = 0,463). A ureia pré-diálise diminuiu no grupo probiótico, mas a diferença entre os grupos não foi significativa (p = 0,305). O fósforo sérico apresentou uma redução maior no grupo probiótico do que no grupo placebo (p = 0,011; ANCOVA p = 0,011). Não foram observadas diferenças significativas nos desfechos antropométricos ou hemodinâmicos. Conclusão: Seis meses de suplementação com probióticos não reduziram significativamente os níveis séricos de zonulina em pacientes em hemodiálise. Embora tenha sido observado um efeito favorável sobre o fósforo sérico, esses resultados não comprovam um impacto mensurável desse regime probiótico sobre a zonulina sérica, e sinalizam a necessidade de estudos maiores que incorporem avaliações diretas da permeabilidade intestinal e da microbiota intestinal.
Scorpion envenoming is primarily recognized as a neurotoxic syndrome, but increasing evidence suggests that inflammatory responses may contribute to its systemic effects. The clinical relevance of these responses in patients with mild envenoming remains poorly characterized. This study investigated serum interleukin-6 (IL-6) and its association with angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) in adults with mild Tityus stigmurus envenoming. A cross-sectional study was conducted in 80 adults treated for scorpion envenoming at a referral hospital in Northeast Brazil, between August 2025 and April 2026. Clinical, hematological, biochemical, and serum biomarker parameters were evaluated. IL-6, Ang-1, and Ang-2 were quantified by enzyme-linked immunosorbent assay. Patients were classified according to detectable or undetectable serum IL-6, using 7 pg/mL as the assay detection threshold. All patients had mild envenoming, no systemic clinical manifestations, and favorable outcomes. IL-6 was detectable in 17 patients (21.3%). Patients with detectable IL-6 had higher Ang-2 concentrations than those with undetectable IL-6 (3.94 vs. 1.03 ng/mL, p = 0.006) and a higher Ang-2/Ang-1 ratio (0.091 vs. 0.027, p = 0.003). Ang-1 concentrations did not differ between groups (p = 0.524). IL-6 showed a moderate positive correlation with Ang-2 (ρ = 0.549, p = 0.022). Conventional hematological, renal, hepatic, and pancreatic parameters did not differ significantly according to IL-6 status. These findings indicate that mild T. stigmurus envenoming may induce detectable inflammatory activation despite the absence of systemic clinical manifestations. The association between IL-6 and Ang-2 suggests a link between inflammatory and endothelial responses and supports IL-6 as a candidate marker for investigating the clinical effects of scorpion venom.